文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

英格兰男男性行为者经性传播出现的广泛耐药与多重耐药福氏志贺菌2a型:描述性流行病学研究

Emergence of extensively drug-resistant and multidrug-resistant Shigella flexneri serotype 2a associated with sexual transmission among gay, bisexual, and other men who have sex with men, in England: a descriptive epidemiological study.
PubMed 文献 · Lancet Infect Dis · 2023-01-30

该研究对英格兰2015年9月1日至2022年6月12日提交至英国卫生安全局胃肠道细菌参考实验室的携带blaCTX-M-27的福氏志贺菌分离株进行全基因组测序与系统发育分析。结果显示,2021年9月起此类病例持续增加(n=26),而此前6年仅11例;形成广泛耐药旁系群(n=8)与多重耐药单系群(n=18),13名完成问卷者中10人为男男性行为者。

要点

  • 2021年9月起携带blaCTX-M-27的福氏志贺菌病例持续增加(n=26),此前6年仅11例。
  • 形成广泛耐药旁系群(n=8)与多重耐药单系群(n=18),均属福氏志贺菌2a型。
  • 13名完成问卷者中10人(77%)为男男性行为者,4人(31%)住院。

核心结论

  • 研究报道英格兰男男性行为者中出现携带blaCTX-M-27的广泛耐药与多重耐药福氏志贺菌2a型。
  • 与广泛耐药宋内志贺菌暴发株的流行病学及质粒相似性支持水平获得事件,强调可移动抗菌药物耐药性的重要性和基于基因组监测的必要性。

研究设计与样本

  • 描述性流行病学研究,鉴定并系统发育分析提交至英国卫生安全局胃肠道细菌参考实验室的携带blaCTX-M-27的福氏志贺菌分离株。
  • 所有提交分离株均行全基因组测序,利用遗传标志判定抗菌药物耐药性。
  • 病例定义为2015年9月1日至2022年6月12日标本日期、经系统发育确认属于两个t10(约十个单核苷酸多态性)聚集群的英格兰携带blaCTX-M-27的福氏志贺菌感染者。
  • 长读长测序阐明blaCTX-M-27的基因组位置;实验室数据结合问卷可获得的人口学与临床信息,用描述性统计汇总。

主要发现

  • 携带blaCTX-M-27的福氏志贺菌病例自2021年9月起持续增加(n=26),此前6年仅散在报告(n=11)。
  • 福氏志贺菌2a型内blaCTX-M-27获得事件形成广泛耐药旁系群(n=8)和多重耐药单系群(n=18)。
  • 病例均为成年男性(中位年龄37岁[IQR 31-46]);13名完成问卷者中10人(77%)为男男性行为者。
  • 13人中7人(54%)接受抗菌药物治疗,4人(31%)住院。
  • 携带blaCTX-M-27的IncFII质粒与广泛耐药宋内志贺菌暴发质粒高度相似,聚集群质粒与暴发质粒核苷酸相似性分别为82%和99%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Shigellosis, also known as bacillary dysentery, is caused by Shigella spp that spread through fecal-oral contact and was traditionally associated with international travel in England. However, sexual transmission of Shigella flexneri and Shigella sonnei among gay, bisexual, and other men who have sex with men (MSM) is now common. In September, 2021, emergence of extensively drug-resistant (XDR) S sonnei harbouring plasmid-encoded blaCTX-M-27 raised concerns over further spread of this extended-spectrum β-lactamase-producing gene. Using national surveillance in England, we identified and characterised isolates of S flexneri harbouring blaCTX-M-27. METHODS: In this epidemiological study, we identified and phylogenetically characterised S flexneri isolates harbouring blaCTX-M-27 that were referred to the Gastrointestinal Bacterial Reference Unit (GBRU) at the UK Health Security Agency. All isolates referred to the GBRU undergo whole-genome sequencing, enabling antimicrobial resistance determination using genetic markers. Cases were defined as individuals diagnosed with S flexneri harbouring blaCTX-M-27 in England, with a specimen date between Sept 1, 2015, and June 12, 2022, who were phylogenetically confirmed as part of two t10 (approximately ten single nucleotide polymorphisms) clusters. Long-read sequencing elucidated the genomic location of blaCTX-M-27. Laboratory data, integrated with available demographic and clinical information from patient questionnaires, were summarised using descriptive statistics. FINDINGS: A sustained increase in cases of S flexneri harbouring blaCTX-M-27 (n=26) occurred from September, 2021, having been sporadically reported (n=11) in the preceding 6 years. blaCTX-M-27 acquisition events within S flexneri 2a established an XDR paraphyletic (n=8) cluster and a multidrug-resistant monophyletic (n=18) cluster. Cases were among adult male individuals (median age 37 years [IQR 31-46]) and, of the 13 individuals who completed a patient questionnaire, ten (77%) identified as MSM. Antimicrobial treatment was received by seven (54%) of 13 individuals, and four (31%) individuals were admitted to hospital. The IncFII plasmids harbouring blaCTX-M-27 showed high similarity to the XDR S sonnei outbreak plasmid, with 82% and 99% nucleotide similarity between the cluster plasmids and the XDR S sonnei outbreak plasmid. INTERPRETATION: We report emergence of XDR and multidrug-resistant S flexneri 2a harbouring blaCTX-M-27 among MSM in England. Epidemiological and plasmid similarities with the XDR S sonnei outbreak support horizontal acquisition events, emphasising the importance of mobilisable antimicrobial resistance and the need for genomic-based surveillance. FUNDING: National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool in partnership with the UK Health Security Agency.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Thorley K, Charles H, Greig DR, et al. Emergence of extensively drug-resistant and multidrug-resistant Shigella flexneri serotype 2a associated with sexual transmission among gay, bisexual, and other men who have sex with men, in England: a descriptive epidemiological study. Lancet Infect Dis. 2023. PMID: 36731481. doi:10.1016/S1473-3099(22)00807-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。